Influences of Dysregulated Resistin mRNA and Its Plasma Protein Levels on the Risk of Incident Type 2 Diabetes in Subjects with Obesity

Faculty Medicine Year: 2024
Type of Publication: ZU Hosted Pages: 9
Authors:
Journal: zagazig university medical journal zagazig university medical journal Volume:
Keywords : Influences , Dysregulated Resistin mRNA , , Plasma Protein    
Abstract:
ABSTRACT Background: Resistin is an adipokine involved in developing obesity, insulin resistance, and comorbidities, such as type 2 diabetes mellites (T2DM). The present study aimed to estimate the circulating levels of Resistin mRNA and its plasma protein in patients with obesity in children vs adults and to correlate their levels with metabolic dysfunction parameters particularly, T2DM. Methods: This study included 80 subjects: 30 healthy subjects as the control group and 50 obese patients. The enrolled patients were classified into a pediatric group (n=25, age 8-18 years) and an adult group (n=25, age >18). Circulating resistin was measured by ELISA,and resistin mRNA was determined by real-time PCR. Results: Among the obese pediatric group, plasma resistin and its mRNA levels were significantly higher in the T2DM obese group( 15.4±1.26 and 2.51±0.31, respectively ) in comparison to other group ( 9.9±2.17, and 1.6±0.43, respectively), P <0 .001.Additionally, in the obese adult group, plasma resistin and its mRNA levels were significantly higher in the T2DM obese group (37.2±3.8and 6.54±0.56, respectively ) in comparison to other group ( 20.4±2.287, and 4.34±0.263, respectively ), P <0 .001. Interestingly, Age, BMI, FPG,2 HPP, FSI, HOMA-IR, HbA1c, and LDL values were significantly positively correlated with plasma resistin and its mRNA values. Conclusions: Plasma resistin and its mRNA were elevated in obese subjects, especially those with T2DM.In addition, plasma resistin and its mRNA values were significantly positively correlated with metabolic dysfunction parameters. Keywords: Obesity; Type 2 diabetes mellitus; resistin; children; Metabolic dysfunction.
   
     
 
       

Author Related Publications

  • George Emad Shaker Rizk, "Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus", Braz. J. Nephrol, 2019 More
  • George Emad Shaker Rizk, "urinary sE-cadherin and plasma cystatin c as novel biomarkers of diabetic nephropathy", جامعة الزقازيق, 2014 More
  • George Emad Shaker Rizk, "Urinary netrin-1 predicts early ischemic acute kidney injury after cardiopulmonary bypass", Wolters Kluwer, 2019 More
  • George Emad Shaker Rizk, "Anti c1q antibodies in lupus nephritis and their correlation with the disease activity", Riyadh : Saudi Center for Organ Transplantation, c, 2019 More
  • George Emad Shaker Rizk, "Serum Levels of Transforming Growth Factor Beta -1 (TGF-β1) as An Early No Invasive Marker for Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus Patients", Modern commercial press, 2019 More

Department Related Publications

  • Mohamed El Sayed Mohammed Mustafa, "Prevalence of Catheter Related Central Vein Stenosis in Hemodialysis Patients (two centers study)", International Journal of Advanced Research (2014), Volume 2, Issue 11, 1005-1011, 2014 More
  • Mohamed Essam El Din Ahmd, "Does Resistin Gene Polymorphisms +299 (G>A) Participate in Insulin Resistance in Egyptian Non-obese Type 2 Diabetes?", International Journal of Genomic Medicine 2014,vol.2. Issue,1.1000117, 2104 More
  • Ahmed Ibrahim Ibrahim Elagroudy, "Interleukin 28 B Gene Polymorphisms as a Predictor of Treatment Response in Egyptians with Chronic Hepatitis C", Zagazig University Medical Journal, 2014 More
  • Munkez Mutee Yusuf Muhamed, "علاقة الارتداد المعدى بالمرى وارتشاح الاذن الوسطى", لايوجد, 1900 More
  • Khaled Abdelnaby Khodary Mohamed Elhefnawy, "الاديبونيكتين في المصل كدلالة بيولوجية مبكرة لنشاط مرض الذئبة الحمراء والتهاب الكلى Serum Adiponectin as an Early Biomarker of Systemic Lupus Erythematosus activity and lupus nephritis.", Japan International cultural Exchange foundation, 2020 More
Tweet